Swallowing and oral intake outcomes over time.

Dysphagia is a prevalent and debilitating sequela in patients with oral cavity and oropharyngeal cancers undergoing surgery, often complicated by adjuvant radiotherapy or chemoradiotherapy. This prospective cohort study aimed to describe the longitudinal changes in swallowing and oral intake and assess the influence of adjuvant treatment modalities. We included 89 patients with oral cavity or oropharyngeal squamous cell carcinoma. Swallowing was assessed at 1, 3, and 6 months post-surgery using Eating Assessment Tool-10 (EAT-10), Swallowing Ability and Safety Scale (SASS), Functional Oral Intake Scale (FOIS), and Fiberoptic Endoscopic Evaluation of Swallowing (FEES). Patients were stratified by adjuvant treatment: none, radiotherapy, or chemoradiotherapy. Swallowing recovery was dynamic. EAT-10 scores increased from 8.8 at 1 month to peak at 13.5 at 3 months (p

吞咽障碍（Dysphagia）是接受手术治疗的口腔及口咽癌患者高发的致残性后遗症，辅助放疗或放化疗往往会进一步加重该病症的发生与进展。本项前瞻性队列研究旨在阐明吞咽功能与经口进食状态的纵向变化，并评估辅助治疗方式对其产生的影响。研究共纳入89例口腔或口咽鳞状细胞癌患者，分别于术后1、3、6个月采用进食评估问卷-10（Eating Assessment Tool-10, EAT-10）、吞咽能力与安全性量表（Swallowing Ability and Safety Scale, SASS）、经口进食功能量表（Functional Oral Intake Scale, FOIS）以及吞咽纤维内镜检查（Fiberoptic Endoscopic Evaluation of Swallowing, FEES）对患者吞咽功能进行评估。本研究按辅助治疗情况将患者分为三组：无辅助治疗、单纯放疗及辅助放化疗。吞咽功能恢复呈动态变化趋势，EAT-10评分从术后1个月的8.8分升至术后3个月的峰值13.5分（p